Parallel Advisors, LLC Spring Works Therapeutics, Inc. Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
A detailed history of Parallel Advisors, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 4,218 shares of SWTX stock, worth $199,975. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,218
Previous 7,064
40.29%
Holding current value
$199,975
Previous $255,000
21.96%
% of portfolio
0.0%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.3MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$339 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$266 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$164 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$155 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$142 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.96B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...